Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Protara Therapeutics Inc. TARA

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).


Recent & Breaking News (NDAQ:TARA)

SHAREHOLDER ALERT: WeissLaw LLP Investigates Proteon Therapeutics, Inc.

PR Newswire November 21, 2019

Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders - FCSC, PRTO, ARTX, ROAN

GlobeNewswire November 1, 2019

Proteon Therapeutics Announces Third Quarter 2019 Financial Results

GlobeNewswire October 31, 2019

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Acquisitions

GlobeNewswire October 24, 2019

Merger Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders - DOVA, VSI, PRTO

GlobeNewswire October 22, 2019

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Proteon Therapeutics, Inc. (NASDAQ CM: PRTO)

ACCESSWIRE IA October 22, 2019

SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders - PRTO, ROAN, PGNX

ACCESSWIRE IA October 18, 2019

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Proteon Therapeutics, Inc. (NASDAQ CM: PRTO)

ACCESSWIRE IA October 18, 2019

PGNX, PRTO, and ARTX SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

GlobeNewswire October 17, 2019

Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders - PRTO, FCSC, SEMG, UCFC

GlobeNewswire October 15, 2019

Lifshitz & Miller LLP Announces Investigation of Arotech Corporation, Dova Pharmaceuticals, Inc., Highlands Bankshares, Inc., Progenics Pharmaceuticals, Inc., Proteon Therapeutics, Inc., Roan Resources, Inc., SemGroup Corporation and The Stars Group Inc.

PR Newswire October 8, 2019

PROTEON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Proteon Therapeutics, Inc. - PRTO

Business Wire October 3, 2019

HLND, UCFC, and TRCB SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

GlobeNewswire September 26, 2019

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Merger of Proteon Therapeutics, Inc. with ArTara Therapeutics, Inc. is Fair to PRTO Shareholders

GlobeNewswire September 25, 2019

Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Proteon Therapeutics, Inc. (NASDAQ: PRTO) on Behalf of Proteon Shareholders and Encourages Proteon Investors to Contact the Firm

PR Newswire September 25, 2019

PROTEON THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Merger

ACCESSWIRE IA September 24, 2019

PRTO, ARTX Shareholder Investigation: Halper Sadeh LLP is Investigating Whether the Sale of These Companies is Fair to Shareholders - PRTO, ARTX

GlobeNewswire September 24, 2019

Proteon Therapeutics and ArTara Therapeutics Agree to Combine

GlobeNewswire September 23, 2019

Proteon Therapeutics Announces Second Quarter 2019 Financial Results

GlobeNewswire August 7, 2019

Proteon Therapeutics Announces First Quarter 2019 Financial Results

GlobeNewswire May 8, 2019